• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    3/23/23 1:11:21 PM ET
    $ACN
    $AGRX
    $AI
    $AMBI
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACN alert in real time by email

    Gainers

    • DiamondHead Holdings Corp. (NASDAQ:DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
    • Boxed, Inc. (NYSE:BOXD) gained 59.1% to $0.2862 after gaining around 50% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares climbed 36.8% to $2.16. ZyVersa Therapeutics recently reported new employment inducement grants under Nasdaq Listing Rule 5635(c)(4).
    • CXApp Inc. (NASDAQ:CXAI) climbed 29.4% to $2.20.
    • Generation Bio Co. (NASDAQ:GBIO) gained 27% to $4.9299.
    • SMX (Security Matters) Public Limited Company (NYSE:SMX) gained 26.4% to $1.2016.
    • KludeIn I Acquisition Corp. (NASDAQ:INKA) rose 26.3% to $12.63.
    • BM Technologies, Inc. (NASDAQ:BMTX) shares gained 25.5% to $3.35. BM Technologies secured new bank partner and extended key partnerships.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) climbed 24.7% to $0.9878.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) gained 21% to $1.8685.
    • Kineta, Inc. (NASDAQ:KA) jumped 20.4% to $3.83.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) rose 19.7% to $3.28.
    • scPharmaceuticals Inc. (NASDAQ:SCPH) surged 19.2% to $8.25 after the company reported better-than-expected Q4 EPS results.
    • VNET Group, Inc. (NASDAQ:VNET) gained 19.1% to $3.5480. VNET Group reported mixed Q4 financial results.
    • Aziyo Biologics, Inc. (NASDAQ:AZYO) rose 18.5% to $1.41 after posting upbeat Q4 results.
    • Bird Global, Inc. (NYSE:BRDS) shares rose 17.2% to $0.1412 after dropping around 7% on Wednesday. Bird announced plans to expand across Greater Toronto area this spring.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) climbed 17.2% to $6.13.
    • Worthington Industries, Inc. (NYSE:WOR) jumped 16% to $61.67 following better-than-expected Q3 results.
    • Rackspace Technology, Inc. (NYSE:RXT) gained 15.7% to $1.9150.
    • PaxMedica, Inc. (NASDAQ:PXMD) jumped 15.6% to $2.0350.
    • Steelcase Inc. (NYSE:SCS) rose 14% to $8.19 after the company reported better-than-expected Q4 financial results and issued Q1 EPS and revenue guidance above estimates.
    • Agora, Inc. (NASDAQ:API) gained 13.8% to $3.6350.
    • Hesai Group (NASDAQ:HSAI) rose 12.8% to $14.49.
    • 89bio, Inc. (NASDAQ:ETNB) climbed 11.6% to $15.23 after the company announced a proposed underwritten public offering of common stock and pre-funded warrants.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) gained 11.5% to $3.26.
    • Netflix, Inc. (NASDAQ:NFLX) climbed 8.9% to $320.05.
    • C3.ai, Inc. (NYSE:AI) shares rose 8.7% to $24.73.
    • Snap Inc. (NYSE:SNAP) surged 8.1% to $11.94.
    • KB Home (NYSE:KBH) rose 8.1% to $39.79 after the company reported better-than-expected Q1 results.
    • Accenture plc (NYSE:ACN) gained 6.8% to $270.72 after the company reported better-than-expected Q2 results.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) gained 5.6% to $0.2797 following better-than-expected Q4 results.

    Losers

    • Zura Bio Limited (NASDAQ:ZURA) shares dipped 23.1% to $23.07.
    • Vicarious Surgical Inc. (NYSE:RBOT) fell 22.7% to $1.76.
    • Jeffs' Brands Ltd (NASDAQ:JFBR) dropped 20.7% to $0.7253.
    • Minim, Inc. (NASDAQ:MINM) fell 18.8% to $0.1275 after gaining 17% on Wednesday. The company is expected to report Q4 results on March 29, 2023.
    • JanOne Inc. (NASDAQ:JAN) dropped 18.8% to $1.04 after the company announced a registered direct offering of common stock priced at-the-market.
    • ATIF Holdings Limited (NASDAQ:ATIF) fell 18.5% to $1.83.
    • Society Pass Incorporated (NASDAQ:SOPA) dropped 17.2% to $1.01 after the company reported worse-than-expected Q4 sales results.
    • Ambipar Emergency Response (NYSE:AMBI) fell 16.1% to $8.60.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares fell 15.5% to $1.6050 after the company reported worse-than-expected Q4 EPS and sales results.
    • Protagenic Therapeutics, Inc. (NASDAQ:PTIX) dropped 15.4% to $1.49.
    • Vaccitech plc (NASDAQ:VACC) fell 15% to $2.33.
    • Block, Inc. (NYSE:SQ) shares tumbled 13.4% to $62.90 after short seller Hindenburg Research put out a bearish report on the company.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) dropped 13.3% to $4.8543.
    • Coinbase Global, Inc. (NASDAQ:COIN) fell 12.7% to $67.32 after the company received a Wells Notice from the SEC alleging violations of federal securities laws in regards to the company's spot market and staking service. Oppenheimer downgraded Coinbase from Outperform to Perform.
    • Trupanion, Inc. (NASDAQ:TRUP) dropped 12.6% to $48.90 after the company announced a CFO transition.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 12.5% to $0.4187.
    • Movado Group, Inc. (NYSE:MOV) fell 11.8% to $27.32 after the company reported Q4 results.
    • Uranium Energy Corp. (NYSE:UEC) dipped 10.8% to $2.8450 after Kerrisdale Capital issued a short report on the stock.
    • Puyi Inc. (NASDAQ:PUYI) dropped 9.9% to $6.13.
    • Chewy, Inc. (NYSE:CHWY) shares fell 7.2% to $35.01. Chewy reported better-than-expected earnings and sales results for its fourth quarter. However, the company's active customers came in at 20.4 million, down 1.2% from a year ago.
    • Pharming Group N.V. (NASDAQ:PHAR) fell 6.7% to $10.63.

    Now Read This: Top 5 Industrials Stocks That Are Ticking Portfolio Bombs

    Get the next $ACN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACN
    $AGRX
    $AI
    $AMBI

    CompanyDatePrice TargetRatingAnalyst
    Netflix Inc.
    $NFLX
    3/2/2026$115.00Equal Weight
    Barclays
    Netflix Inc.
    $NFLX
    3/2/2026$120.00Overweight
    Analyst
    Netflix Inc.
    $NFLX
    2/27/2026$115.00Outperform
    Evercore ISI
    Netflix Inc.
    $NFLX
    2/27/2026Neutral → Buy
    Arete
    C3.ai Inc.
    $AI
    2/26/2026Mkt Outperform → Mkt Perform
    Citizens
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Accenture plc
    $ACN
    2/17/2026$275.00Equal Weight → Overweight
    Wells Fargo
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    More analyst ratings

    $ACN
    $AGRX
    $AI
    $AMBI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays resumed coverage on Netflix with a new price target

    Barclays resumed coverage of Netflix with a rating of Equal Weight and set a new price target of $115.00

    3/2/26 9:08:09 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Analyst resumed coverage on Netflix with a new price target

    Analyst resumed coverage of Netflix with a rating of Overweight and set a new price target of $120.00

    3/2/26 9:08:09 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Evercore ISI resumed coverage on Netflix with a new price target

    Evercore ISI resumed coverage of Netflix with a rating of Outperform and set a new price target of $115.00

    2/27/26 8:31:30 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ACN
    $AGRX
    $AI
    $AMBI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACN
    $AGRX
    $AI
    $AMBI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Ai Biotechnology Llc bought $12,500,000 worth of Class A Ordinary Shares (2,000,000 units at $6.25) (SEC Form 4)

    4 - Zura Bio Ltd (0001855644) (Issuer)

    3/2/26 5:55:03 PM ET
    $ZURA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President & CEO Stein Jeffrey disposed of $339,040 worth of shares (5,190 units at $65.33), bought $339,040 worth of shares (4,262 units at $79.55), gifted 1,873 shares and received a gift of 937 shares, decreasing direct ownership by 44% to 5,763 units (SEC Form 4)

    4 - Cidara Therapeutics, Inc. (0001610618) (Issuer)

    1/7/26 8:12:25 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Nejatian Kasra bought $1,004,562 worth of shares (125,000 units at $8.04), increasing direct ownership by 0.15% to 83,478,299 units (SEC Form 4)

    4 - Opendoor Technologies Inc. (0001801169) (Issuer)

    11/12/25 8:27:43 AM ET
    $OPEN
    Real Estate
    Finance

    $ACN
    $AGRX
    $AI
    $AMBI
    SEC Filings

    View All

    SEC Form 6-K filed by Agora Inc.

    6-K - Agora, Inc. (0001802883) (Filer)

    3/3/26 6:07:28 AM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    SEC Form EFFECT filed by Jeffs' Brands Ltd

    EFFECT - Jeffs' Brands Ltd (0001885408) (Filer)

    3/3/26 12:15:10 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    Protagenic Therapeutics Inc. filed SEC Form 8-K: Leadership Update

    8-K - Protagenic Therapeutics, Inc.\new (0001022899) (Filer)

    3/2/26 9:27:00 PM ET
    $PTIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACN
    $AGRX
    $AI
    $AMBI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight

    LAS VEGAS, March 2, 2026 /PRNewswire/ -- The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing adoption of targeted therapies and immuno-oncology approaches is expanding treatment options. Additionally, the launch of emerging drugs such as Tinengotinib (TransThera Sciences), Rilvegostomig (AstraZeneca), Nanvuranlat (JPH203) (J-Pharma/OHARA Pharmaceutical), Tovecimig (CTX-009) (Compass Therapeutics), Lenvatinib mesylate (LENVIMA) (Merck/Eisai), and others will further boost the market growth. Recently published Biliary Tract Cancer Market Insights report includes a comprehensive understanding of current

    3/2/26 5:31:00 PM ET
    $BOLD
    $CMPX
    $INCY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Biotechnology: Commercial Physical & Biological Resarch

    Agora, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    SANTA CLARA, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ:API) (the "Company"), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. "We are pleased to report our fifth consecutive quarter of GAAP profitability, marking our first full year of profitability since 2018, driven by sustained double-digit revenue growth," said Tony Zhao, Founder, Chairman, and CEO of Agora, Inc. "Our platform's scalability was validated during a high-profile Super Bowl live shopping event, where we streamed full HD video to nearly 600,000 peak concurrent

    3/2/26 5:00:00 PM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.474 Million Tokens, and Total Crypto and Total Cash Holdings of $9.9 Billion

    Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,976 per ETH; MAVAN staking solution on track to launch Q1 2026Bitmine now owns 3.71% of the ETH token supply, over 74% of the way to the 'Alchemy of 5%' in just 8 monthsBitmine recently closed on initial $200 million investment into Beast IndustriesBitmine Crypto + Total Cash Holdings + "Moonshots" total $9.9 billion, including 4.474 million ETH tokens, total cash of $868 million, and other crypto holdingsBitmine leads crypto treasury peers by both the velocity of raising crypto NAV per share and by the high trading liquidity of BMNR stockBitmine is the 145th most traded stock in the US, trading $0.8 billion per day (5-day avg

    3/2/26 8:30:00 AM ET
    $BMNR
    $COIN
    $MSTR
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $ACN
    $AGRX
    $AI
    $AMBI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Human Resources Officer Teal-Guess Kellie sold $38,491 worth of shares (21,266 units at $1.81), decreasing direct ownership by 2% to 1,022,384 units (SEC Form 4)

    4 - Rackspace Technology, Inc. (0001810019) (Issuer)

    3/2/26 9:13:20 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Marino Mark A. sold $36,531 worth of shares (20,183 units at $1.81), decreasing direct ownership by 0.92% to 2,172,932 units (SEC Form 4)

    4 - Rackspace Technology, Inc. (0001810019) (Issuer)

    3/2/26 9:13:14 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    EVP, President, Public Cloud Sinha Dharmendra Kumar sold $82,161 worth of shares (45,393 units at $1.81), decreasing direct ownership by 2% to 2,464,180 units (SEC Form 4)

    4 - Rackspace Technology, Inc. (0001810019) (Issuer)

    3/2/26 9:13:08 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ACN
    $AGRX
    $AI
    $AMBI
    Financials

    Live finance-specific insights

    View All

    Agora, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    SANTA CLARA, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Agora, Inc. (NASDAQ:API) (the "Company"), a pioneer and leader in conversational AI and real-time engagement technology, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. "We are pleased to report our fifth consecutive quarter of GAAP profitability, marking our first full year of profitability since 2018, driven by sustained double-digit revenue growth," said Tony Zhao, Founder, Chairman, and CEO of Agora, Inc. "Our platform's scalability was validated during a high-profile Super Bowl live shopping event, where we streamed full HD video to nearly 600,000 peak concurrent

    3/2/26 5:00:00 PM ET
    $API
    Computer Software: Prepackaged Software
    Technology

    Chewy Announces Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal fourth quarter and full year 2025 financial results before the market opens on Wednesday, March 25, 2026. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcas

    3/2/26 7:30:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Rackspace Technology Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $683 million, down 0.4% Year-over-Year; 2025 Revenue of $2,686 million, down 2% Year-over-YearFourth Quarter Private Cloud Revenue of $241 million, down 10% Year-over-Year; 2025 Private Cloud Revenue of $990 million, down 6% Year-over-YearFourth Quarter Public Cloud Revenue of $442 million, up 6% Year-over-Year; 2025 Public Cloud Revenue of $1,696 million up 1% Year-over-YearFourth Quarter Cash Flow From Operating Activities of $60 million; 2025 Cash Flow From Operating Activities of $151 million SAN ANTONIO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announc

    2/26/26 8:00:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ACN
    $AGRX
    $AI
    $AMBI
    Leadership Updates

    Live Leadership Updates

    View All

    Chewy Appoints Chris Deppe as Chief Financial Officer

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D

    2/24/26 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Zura Bio Welcomes Accomplished Drug Development Leaders Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to Board of Directors

    Zura Bio Limited (NASDAQ:ZURA) ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced the appointments of Mark Eisner, M.D., M.P.H., and Ajay Nirula, M.D., Ph.D., to its Board of Directors, effective February 21, 2026. As part of this transition, Neil Graham, M.B.B.S., M.D., M.P.H., will step down from the Board effective the same date. "Mark and Ajay are accomplished immunology executives who have successfully guided innovative biologics from early development through approval and commercialization on a

    2/23/26 6:30:00 AM ET
    $ZURA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    VNET Appoints New Officer to Finance Leadership Team

    BEIJING, Feb. 13, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced the appointment of Mr. Peter Zhihua Zhang as Senior Vice President, Operational Finance, effective immediately. Mr. Zhang will be responsible for the Company's financial operations and is authorized to review and approve the Company's financial statements and related filings for SEC and Nasdaq compliance purposes, as applicable. Mr. Zhang will also serve as the Company's "principal accounting officer" in accordance with applicable U.S. federal securities laws, SEC rules, and Nasdaq requirements.

    2/13/26 7:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    $ACN
    $AGRX
    $AI
    $AMBI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Generation Bio Co.

    SC 13G/A - Generation Bio Co. (0001733294) (Subject)

    12/9/24 6:18:02 PM ET
    $GBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/4/24 4:15:14 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care